- Home
- MRT vs TIL Comparison
MRT vs TIL Comparison
Compare MRT & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRT
- TIL
- Stock Information
- Founded
- MRT 2018
- TIL 2018
- Country
- MRT Turkey
- TIL United States
- Employees
- MRT N/A
- TIL N/A
- Industry
- MRT Rental/Leasing Companies
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- MRT Consumer Discretionary
- TIL Health Care
- Exchange
- MRT Nasdaq
- TIL Nasdaq
- Market Cap
- MRT 192.2M
- TIL 171.7M
- IPO Year
- MRT N/A
- TIL 2021
- Fundamental
- Price
- MRT $3.11
- TIL $17.21
- Analyst Decision
- MRT
- TIL Buy
- Analyst Count
- MRT 0
- TIL 5
- Target Price
- MRT N/A
- TIL $114.00
- AVG Volume (30 Days)
- MRT 47.5K
- TIL 85.6K
- Earning Date
- MRT 08-08-2018
- TIL 03-04-2025
- Dividend Yield
- MRT N/A
- TIL N/A
- EPS Growth
- MRT N/A
- TIL N/A
- EPS
- MRT N/A
- TIL N/A
- Revenue
- MRT $18,953,502.00
- TIL N/A
- Revenue This Year
- MRT N/A
- TIL N/A
- Revenue Next Year
- MRT $101.81
- TIL N/A
- P/E Ratio
- MRT N/A
- TIL N/A
- Revenue Growth
- MRT N/A
- TIL N/A
- 52 Week Low
- MRT $0.81
- TIL $9.62
- 52 Week High
- MRT $3.89
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- MRT 46.23
- TIL 42.69
- Support Level
- MRT $2.80
- TIL $17.87
- Resistance Level
- MRT $3.28
- TIL $19.61
- Average True Range (ATR)
- MRT 0.22
- TIL 1.68
- MACD
- MRT -0.01
- TIL -0.06
- Stochastic Oscillator
- MRT 38.27
- TIL 5.69
About MRT Marti Technologies Inc.
Marti Technologies Inc is a mobility app, operating a fleet of over 48,000 e-mopeds, e-bikes, and e-scooters, serviced by proprietary software systems and IoT infrastructure.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.